From June 7, 2024 to June 30, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on June 8, 2024.
Shanghai Aladdin Biochemical Technology Co.,Ltd.
Equities
688179
CNE100005XD0
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.71 CNY | -0.82% |
|
+3.41% | -29.05% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.05% | 371M | |
+25.83% | 47.96B | |
+0.69% | 42.45B | |
+44.42% | 41.47B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- 688179 Stock
- News Shanghai Aladdin Biochemical Technology Co.,Ltd.
- Tranche Update on Shanghai Aladdin Biochemical Technology Co.,Ltd.'s Equity Buyback Plan announced on June 8, 2024.